Company intelligence / Profile preview

AirSculpt Technologies

Beverly Hills, California, United States

Ownership: Private
Development stage: Other

Overview

AirSculpt Technologies operates a network of 28 clinics offering the patented AirSculpt® procedure, a minimally invasive, device-based fat removal and body contouring solution. The company reported $134.5 million in revenue during the first three quarters of 2024. Recent clinical performance is measured in terms of procedure volume, patient satisfaction, and safety, with approximately 3,600 procedures performed in Q3 2024. No formal clinical drug trials as the product is procedural/device-based, not pharmacological.

Therapeutic areas: OtherMetabolic Disorders
Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on AirSculpt Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AirSculpt Technologies.

Explore the full profile